Doug Hubatsch is the Chief Scientific Officer at Nicox, an international ophthalmology company focused on developing innovative solutions for ocular health.
Doug Hubatsch is the Chief Scientific Officer at Nicox, an international ophthalmology company focused on developing innovative solutions for ocular health. In this role, he leads the company's non-clinical and clinical development activities and is responsible for setting the research and development strategy. Hubatsch has over 25 years of experience in Discovery Research, Development, and Medical Affairs, including previous roles at Novartis Pharmaceuticals, Alcon, Roche, and AstraZeneca, and has been involved in the launch of more than 10 products.
Full founder directory · Investor directory · Company funding database · Fundraising library